Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn։
”During my stay in Lisbon I had a privilege to give a lecture for Polish cardiologists about ‘Anticoagulation in specific situations’ during special pre-ACVC event.
Anticoagulation in real life causes lot of dilemmas, and we are increasingly forced to make individualized decisions and move towards patient-oriented precise medicine.
With Christophe Vandenbriele we wrote last year one of the Association for Acute Cardio Vascular Care – ACVC Clinical Decision Making Toolkit chapters: 10.2 Managing anticoagulation in critically ill in specific situations, which includes i.e. bleeding on OAC, anticagulation and hemolysis during MCS, heparin-induced thrombocytopenia, and MV thrombosis.”
Stay updated with Hemostasis Today.
-
Jun 28, 2026, 05:17Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
-
Jun 28, 2026, 05:08Kathrine Kaspersen: The Power of Voluntary Plasma Donation
-
Jun 28, 2026, 04:55Sana Helani: Challenging Common Assumptions in Anemia Management
-
Jun 28, 2026, 04:55Samwel Mikaye: The Collapse of Coagulation Control in Disseminated Intravascular Coagulation
-
Jun 28, 2026, 04:45Abolfazl Miri: Improving ITP Diagnosis with Readily Available Hematological Indices
-
Jun 28, 2026, 04:22Jensa Morris: Why Low Molecular Weight Heparins Should Be the First Choice for VTE
-
Jun 28, 2026, 03:57Sara Zalghout: Navigating the Often-Unspoken Challenges of Academia at ISTH 2026
-
Jun 28, 2026, 02:56Carlo Alfieri: Redefining Anemia Management After Kidney Transplantation
-
Jun 28, 2026, 02:36Ramesh Chennupat: Anemia is Associated with Increased REV Release in Stable Coronary Artery Disease